ZYNE Historical Earnings image   This ZYNE historical earnings page last updated 8/19/2022
ZYNE Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/10/2022NA
Q1 20225/16/2022NA
Q4 20213/1/2022NA
Q3 202111/15/2021NA
Q2 20218/9/2021NA
Q1 20215/12/2021NA
Q4 20203/10/2021NA
Q3 202011/9/2020NA
Q2 20208/10/2020NA
Q1 20205/11/2020NA
Q4 20193/10/2020NA
Q3 201911/6/2019NA
Q2 20198/6/2019NA
Q1 20195/8/2019NA
Q4 20183/11/201986000
Q3 201811/8/2018NA
Q2 20188/2/2018NA
Q1 20185/8/2018NA
Q4 20173/12/2018NA
Q3 201711/14/2017NA
Q2 20178/1/2017NA
Q1 20175/9/2017NA
Q4 20163/27/2017NA
Q3 201611/14/2016NA
Q2 20168/11/2016NA
Q1 20165/12/20167250
Q4 20153/14/201649275
Q3 201511/11/2015199407
ZYNE Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/10/2022-0.240
Q1 20225/16/2022-0.210
Q4 20213/1/2022-0.220
Q3 202111/15/2021-0.260
Q2 20218/9/2021-0.250
Q1 20215/12/2021-0.200
Q4 20203/10/2021-0.330
Q3 202011/9/2020-0.310
Q2 20208/10/2020-0.780
Q1 20205/11/2020-0.530
Q4 20193/10/2020-0.460
Q3 201911/6/2019-0.080
Q2 20198/6/2019-0.500
Q1 20195/8/2019-0.470
Q4 20183/11/2019-0.44
Q3 201811/8/2018-0.47
Q2 20188/2/2018-0.89
Q1 20185/8/2018-0.91
Q4 20173/12/2018-0.6
Q3 201711/14/2017-0.63
Q2 20178/1/2017-0.64
Q1 20175/9/2017-0.6
Q4 20163/27/2017-0.7
Q3 201611/14/2016-0.67
Q2 20168/11/2016-0.7
Q1 20165/12/2016-0.49
Q4 20153/14/2016-0.62
Q3 201511/11/2015-0.44
Quotes delayed 20 minutes

Email EnvelopeFree ZYNE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Zynerba Pharmaceuticals (ZYNE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ZYXI Historical Earnings
A Historical Earnings
AADI Historical Earnings
ABBV Historical Earnings
ABC Historical Earnings
ABEO Historical Earnings
ABIO Historical Earnings
ABMD Historical Earnings
ABOS Historical Earnings
ABSI Historical Earnings
What was the record high ZYNE historical earnings result?
In terms of earnings or revenue, what is the best ZYNE historical earnings result that Zynerba Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ZYNE historical earnings result was set in Q3 2019, when Zynerba Pharmaceuticals posted results of -0.080/share. The most successful revenue quarter within our data set was Q3 2015 when Zynerba Pharmaceuticals reported revenue of 199407.

What was the lowest Zynerba Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ZYNE has reported, and when?

✔️Accepted answer: Within our data set, the lowest ZYNE historical earnings result was set in Q1 2018, when Zynerba Pharmaceuticals posted results of -0.91/share. The smallest revenue quarter within our data set was Q2 2022 when Zynerba Pharmaceuticals reported revenue of NA.

On this page we presented the ZYNE historical earnings date information for Zynerba Pharmaceuticals. Reviewing that ZYNE Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2019, when ZYNE posted gaap of -0.080/share. Meanwhile the lowest ZYNE historical earnings result was in Q1 2018, when ZYNE posted gaap of -0.91/share. Moving to Zynerba Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2015 when ZYNE reported 199407 in revenue, while the smallest revenue quarter was Q2 2022 when ZYNE reported NA in revenue.

For self directed investors doing their due diligence on ZYNE or any other given stock, their research can benefit from looking into all of the Zynerba Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Zynerba Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ZYNE. Thanks for visiting, and the next time you need to research ZYNE historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: STOK Average Annual Return, FRSH Options Chain, Top Ten Hedge Funds Holding SND.

 

ZYNE Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.